Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Endotoxin Control Strategies for Parenteral Drug Product Manufacturing
Robert Simler Associate Director, Engineering and Technology Biogen, Cambridge, MA, USA
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Coupling single-pass TFF before loading onto a chromatography sorbent
Changing Column Packing from an Art into a Science
View All Featured ArticlesHeadline News
RYBREVANT FASPRO combination shows 77% response rate in first-line advanced head and neck cancer
FDA expands TALZENNA plus XTANDI approval to earlier metastatic prostate cancer setting
Sofe-M combination shows 79% response rate in platinum-sensitive ovarian cancer
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
The exogenously driven disruption of Bioprocessing
Presented by Presented by Christos Varsakelis, Team Lead Artificial Intelligence/Machine Learning at The Janssen Pharmaceutical Companies of Johnson & Johnson and Pranjul Mishra, team lead of application science at Yokogawa Insilico Biotechnology
15th September 2022
Can the New generation of perfusion technology compete or replace the conventional and widely preferred fed-batch technology?
Presented by Ankur Bhatnagar, Chief Scientific Manager of Biocon R&D
15th November 2017
Establishing Early Development Strategies For Therapeutics Proteins
Presented by Sorina Morar-Mitrica, Principal Fellow Sr Drug Product Lead Early Phase Biologics at Novartis and Bernardo Cordovez, PhD, Chief Science Officer & Founder, Halo Labs
21st October 2020
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Rationale Design of Valves for Flexible Processing
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
